Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|March 14, 2013
Adjuvant docetaxel and carboplatin chemotherapy administered alone or with radiotherapy in a "sandwich" protocol in patients with advanced endometrial cancer: a single-institution experienceChunyan Lan, Xin Huang, Xinping Cao, et al.Radiation Oncology (London, England)|September 16, 2018
Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysisYanzhu Lin, Kai Chen, Zhiyuan Lu, et al.Cancer Management and Research|October 17, 2018
Knockdown of PKM2 suppresses tumor progression in human cervical cancer by modulating epithelial-mesenchymal transition via Wnt/β-catenin signalingYanzhu Lin, Fanqing Meng, Zhiyuan Lu, et al.International Immunopharmacology|June 9, 2023
Role of chemokines in T-cell acute lymphoblastic Leukemia: From pathogenesis to therapeutic optionsYiFan Zhao, RuiTing Guo, XinPing Cao, et al.Annals of Hematology|October 18, 2023
Alliance between titans: combination strategies of CAR-T cell therapy and oncolytic virus for the treatment of hematological malignanciesXuejin Gao, Jile Liu, Rui Sun, et al.Frontiers in Medicine|July 7, 2025
Development of a predictive tool for long-term prognosis in clear cell adenocarcinoma of the cervix: a large population-based real-world studyYanhong Wang, Yi Ouyang, Yiping Chen, et al.Japanese Journal of Clinical Oncology|January 4, 2021
Is salvage radiotherapy optimal to patients with occult cervical cancer undergoing inadvertent simple hysterectomy? A propensity score-matched analysis of a nationwide clinical oncology databaseYanhong Wang, Yi Ouyang, Jingjing Su, et al.Journal of Cancer|January 2, 2018
Exploration of the optimal treatment regimes for Esthesioneuroblastoma: a single center experience in ChinaYujie Yuan, Jinning Ye, Huizhi Qiu, et al.Current Treatment Options in Oncology|January 26, 2023
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological MalignanciesXinping Cao, Xin Jin, Xiaomei Zhang, et al.Frontiers in Immunology|March 6, 2023
Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkersXiaojing Zheng, Haifeng Gu, Xinping Cao, et al.Pageof 5